Log In
BCIQ
Print this Print this
 

SOM0777

  Manage Alerts
Collapse Summary General Information
Company SOM Biotech S.L.
DescriptionInhibitor of alpha-v beta-3 and alpha-v beta-5 integrins
Molecular Target Integrin alpha(V)beta(3) (CD51/CD61) ; Integrin alpha(V)beta(5)
Mechanism of ActionIntegrin inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationBrain cancer
Indication DetailsTreat glioblastoma multiforme (GBM)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today